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The commonly used inhalation anesthetic isoflurane has been reported to induce DNA
damage and cytotoxicity. However, the methods to attenuate these effects remain
largely to be determined. Mild hypothermia has neuroprotective effects. We therefore
set out to assess whether mild hypothermia could protect the isoflurane-induced
DNA damage and cytotoxicity. Moreover, we investigated the underlying mechanisms
by assessing the effects of mild hypothermia on the isoflurane-induced changes in
ATP levels. H4 human neuroglioma cells were treated with 2% isoflurane for 3 or
6 h with and without mild hypothermia (35◦C). We assessed the cell viability by
using 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) and lactate
dehydrogenase (LDH) assay. We determined DNA damage by measuring levels of
phosphorylation of the histone protein H2A variant X at Ser139 (γH2A.X), the marker
of DNA damage. We also measured ATP levels in the cells. Here we showed that
the treatment with 2% isoflurane for 6 h induced cytotoxicity and DNA damage in the
cells. Moreover, the treatment with 2% isoflurane for 3 h decreased ATP levels without
inducing cytotoxicity. Mild hypothermia attenuated the isoflurane-induced cytotoxicity,
DNA damage, and ATP reduction in the cells. Taken together, these data suggest that
the isoflurane-induced reduction in ATP levels occurred before the isoflurane-induced
cytotoxicity. Isofluranemay induce DNA damage and cause cytotoxicity through reducing
ATP levels. Mild hypothermia would ameliorate isoflurane-induced DNA damage and
cytotoxicity by attenuating the isoflurane-induced reduction in ATP levels. These pilot
studies have established a system andwill promote the future investigations of anesthesia
neurotoxicity.
Keywords: anesthesia, DNA damage, hypothermia, isoflurane, cytotoxicity
INTRODUCTION
Inhalation anesthetic isoflurane has been reported to induce the neurotoxicity associated with
Alzheimer’s disease (AD) neuropathogenesis [Eckenhoff et al., 2004; Loop et al., 2005; Wei et al.,
2005, 2007; Xie et al., 2006, 2007; Lin and Zuo, 2011, reviewed in Vutskits and Xie (2016)].
Moreover, our recent studies have shown that isoflurane can also cause DNA damage (Ni et al.,
2016). Hypothermia has been classified into: mild (34.5–36.5◦C), moderate (34.5–32◦C), marked
(28–32◦C), and profound hypothermia (<28◦C) (Tisherman et al., 1999; Nagel et al., 2008).
Hypothermia has been shown to decrease excitotoxicity, inflammation, free radical levels, and
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intracellular calcium overload, which therefore would protect the
apoptosis (Andresen et al., 2015). Mild hypothermia (e.g., 35◦C)
is a neuroprotective strategy and could be useful to treat brain
injuries (Andresen et al., 2015). However, it remains unknown
whether mild hypothermia can protect the isoflurane-induced
DNA damage and cytotoxicity.
During the cellular senescence or cell death, DNA damage
decreases cellular replication, and contributes to the onset
of the aging process (Hoeijmakers, 2009; López-Otín et al.,
2013). As an aging maker, DNA damage is also associated
with neurodegenerative disease (Coppedè and Migliore, 2015;
Shiwaku and Okazawa, 2015), brain tumors (McKinnon,
2009), and AD (McKinnon, 2009; Canugovi et al., 2012).
Histone protein H2A variant X at Ser139 (γH2A.X) has been
reported as one of the markers for DNA damage (Bonner
et al., 2008; Garcia-Canton et al., 2012; Valdiglesias et al.,
2013; Ni et al., 2016), and isoflurane has been shown to
elevate the levels of γH2A.X in H4 human neuroglioma cells
(Ni et al., 2016). Therefore, we assessed the interaction of
isoflurane and mild hypothermia on the levels of γH2A.X in
the cells.
Moreover, hypothermia can decrease the metabolic rate,
which may then prevent the reduction in ATP levels (Andresen
et al., 2015). Isoflurane has been shown to decrease ATP
levels in vitro (Zhang et al., 2012). We therefore assessed
the interaction of mild hypothermia and isoflurane on the
DNA damage, cytotoxicity, and ATP levels in cultured cells.
The objective of the current study was to establish a system
of interaction of mild hypothermia and isoflurane in cells
and prove a concept that mild hypothermia might protect
the isoflurane-induced DNA damage and cytotoxicity. The
hypothesis in the present study was that mild hypothermia
attenuated the isoflurane-induced DNA damage and cytotoxicity
though preventing the isoflurane-induced reduction in ATP
levels.
MATERIALS AND METHODS
Cell Line
H4 human neuroglioma cells (H4 cells) were used in the studies.
The cells were cultured in DMEM (high glucose) containing 9%
heat-inactivated fetal calf serum, 100 U/ml penicillin, 100 ug/ml
streptomycin, and 2 mM L-glutamine.
Cell Treatments
Isoflurane was delivered from an anesthesia machine to a sealed
plastic box in a 37◦C incubator containing 6-well plates; the 6-
well plates were seeded with onemillion cells in 1.5ml cell culture
media per well, as described in our previous studies (Zhang
et al., 2012). A Dash 400 gas analyzer (General Electric Company,
Boston, MA) was used to continuously monitor the delivered
concentrations of carbon dioxide, oxygen, and isoflurane. The
cells were treated with 2% isoflurane, plus 21% O2, and 5%
CO2 at for a duration of 3 or 6 h as described by our previous
studies (Xie et al., 2006, 2007; Ni et al., 2016). Mild hypothermia
(35◦C) was created by putting the sealed plastic box in a 35◦C
incubator.
Cell Viability Study
Cell viability was determined by using 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyl tetrazolium bromide (MTT) (Sigma, St. Louis,
MO). Experiments were performed as described in the protocol
provided by the company. Briefly, we added 150 µL of MTT (5
mg/mL) solution to each well, containing 1.5 mL of cell culture
medium, on a 6-well plate for treatment with 2% isoflurane
for 6 h. We then returned the cells to the incubator for 2 h.
Finally, we removed the cell culture medium and added 1.5 mL
isopropanol into each well. We spectrophotometrically measured
the absorbance at a wavelength of 570 nm. We presented the
changes in absorbance, as the levels of cell viability, in the
cells treated with isoflurane and/or mild hypothermia as the
percentage of those in the cells treated with control conditions.
The reduction in cell viability (e.g., decrease in MTT levels)
indicates cytotoxicity.
Lactate Dehydrogenase Release (LDH)
Cell membrane integrity or cell viability was also assessed
using a commercial lactate dehydrogenase (LDH) kit (Roche
Applied Science, Madison, WI). Experiments were performed
as described in the protocol provided by the company. Levels
of LDH released into the medium were used to reflect
cell membrane integrity or cell viability. Briefly, after the
treatments of isoflurane and/or mild hypothermia, we collected
the cell culture medium and assessed LDH levels according
to the manufacturer’s instructions. We spectrophotometrically
measured the absorbance at a wavelength of 490 nm. The ratio
of LDH levels in the supernatant to the total LDH levels served
as the index of cell viability. We presented the changes in
absorbance, as the degree of cell viability, in the cells treated with
isoflurane and/or mild hypothermia as the percentage of those
in the cells treated with control condition. The reduction in cell
membrane integrity (e.g., increase in LDH levels) or cell viability
indicates cytotoxicity.
Cell Harvest, Cell Lysis, and Protein
Quantification
The cells were harvested at the end of the experiments for
Western blot analysis. The pellets of the harvested cells were
detergent-extracted on ice using an immunoprecipitation buffer
plus protease inhibitors, as described in our previous studies
(Zhang et al., 2012). The lysates were collected, centrifuged at
13,000 rpm for 15 min, and quantified for total protein amount
by a bicinchoninic acid protein assay kit (Pierce, Rockford, IL).
Western Blot Analyses
Western blot analyses were performed as described in our
previous studies (Zhang et al., 2010, 2012). Specifically, γH2A.X
antibody (1:1000 dilution; Cell Signaling Technology, Danvers,
MA) was used to detect the levels of γH2A.X (15 kDa), and β-
actin antibody (1:10,000, Sigma, St. Louis,MO)was used to detect
β-actin (42 kDa). Each band in the Western blot represented
an independent experiment. The results were averaged from six
independent experiments. The intensity of signals was analyzed
using the National Institute of Health image program. We
quantified the Western blots in two steps. First, we used β-actin
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levels to normalize protein levels (e.g., determining the ratio of
γH2A.X to β-actin amount) and to control for loading differences
in the total protein amount. Secondly, we presented protein level
changes in cells exposed to isoflurane and/or mild hypothermia
as the percentage of those in the control group. One hundred
percentage of the protein level changes refer to the control levels,
for the purpose of comparison to the experimental conditions.
ATP Measurement
We employed the ATP Determination Kit (Invitrogen) in the
experiments to detect ATP levels, as described in our previous
studies (Zhang et al., 2010, 2012). In short, the cells were placed
in 6-well plates in the incubator overnight. The cells were then
exposed to the isoflurane and/or mild hypothermia treatment.
At the end of the treatment, the amount of fluorescence was
measured, and the levels of ATP in the experimental samples
were calculated from the standard curve made from samples
containing known amounts of ATP.
Statistical Analyses
Data were expressed as means ± standard deviation (SD).
The number of samples was 6–8 per group, and the power
calculation was performed using information collected from a
preliminary study that was conducted under the same conditions.
Based on the preliminary data, assuming a two-sided Student-
t-test, samples of 6 for each control and treatment group
would lead to 90% power and 95% significance. Student’s
t-test and one-way ANOVA were used to determine the
difference between the treatment (isoflurane vs. isoflurane
plus hypothermia) and control condition. Post hoc analyses
(Bonferroni test) were conducted if the main effects were found
to be statistically significant. P-values < 0.05 were considered
statistically significant. Prism 6 software (GraphPad software, La
Jolla, CA) was used to analyze the data.
RESULTS
Anesthetic Isoflurane Induced Cytotoxicity
in H4 Cells
The objective of the current study was to find the potential
methods to protect the cytotoxicity induced by anesthetic
isoflurane and to illustrate the underlying mechanisms. Our
previous studies had shown that treatment with 2% isoflurane
for 6 h could induce cytotoxicity in vitro (Xie et al., 2006, 2007;
Zhang et al., 2010, 2012). Therefore, we first assessed the effects
of mild hypothermia on the isoflurane-induced cytotoxicity (e.g.,
cell death). The cell viability was determined by MTT assay. As
can be seen in Figure 1A, MTT assay showed that treatment with
2% isoflurane for 6 h decreased the MTT levels as compared to
control condition: 69.5 vs. 100%. However, mild hypothermia
attenuated the isoflurane-induced reduction in MTT levels: 83.5
vs. 69.5%. One-way ANOVA showed the significant difference
among these three conditions: control, isoflurane, and isoflurane
plus mild hypothermia (Figure 1A, F = 22.99, ∗∗P = 0.001).
Consistently, the mild hypothermia ameliorated the isoflurane-
induced increase in LDH release: 100% (control condition) vs.
163 (isoflurane) vs. 110% (isoflurane plus mild hypothermia;
Figure 1B, F = 14.42, ∗∗P = 0.001). These data suggest that
isoflurane was able to induce the cytotoxicity inH4 cells, andmild
hypothermia could attenuate the isoflurane-induced cytotoxicity
in the cells.
Hypothermia Attenuated the
Isoflurane-Induced Increase in γH2A.X
Levels
Given the findings that mild hypothermia was able to attenuate
the isoflurane-induced cytotoxicity, next we assessed whether the
mild hypothermia could also attenuate the isoflurane-induced
increase in the γH2A.X level, the marker of DNA damage, in the
cells. The immunoblotting of γH2A.X showed that the treatment
FIGURE 1 | Mild hypothermia attenuates the isoflurane-induced cells death in H4 cells. (A) Treatment with 2% isoflurane for 6 h (black bar) decreases the
MTT level as compared to the control condition (white bar). Treatment with 2% isoflurane for 6 h plus hypothermia (net bar) leads to lesser reduction in MTT level as
compared to isoflurane alone (black bar) in the H4 cells. (B) Treatment with 2% isoflurane for 6 h (black bar) increases the LDH level as compared to the control
condition (white bar). Treatment with 2% isoflurane for 6 h plus hypothermia (net bar) leads to lesser increase in LDH level as compared to isoflurane alone (black bar)
in the H4 cells. 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT); lactate dehydrogenase (LDH). N = 6–8 in each group. **Indicates that there are
significant differences between control condition and isoflurane treatment in MTT levels (Panel A) and LDH levels (Panel B). ## Indicates that there are significant
differences between isoflurane treatment and isoflurane plus mild hypothermia treatment in MTT levels (Panel A) and LDH levels (Panel B).
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with 2% isoflurane for 6 h (lanes 5–8) induced visible increases in
the density of bands representing γH2A.X as compared to control
condition (lanes 1–4) (Figure 2A). There was no significant
difference in β-actin level between the isoflurane treatment and
control condition (Figure 2A). The quantification of theWestern
blot (Figure 2B), based on the ratio of γH2A.X to β-actin, showed
that the isoflurane treatment (black bar) increased γH2A.X
level as compared to the control condition (white bar): 348 vs.
100%, ∗∗P = 0.001. Next, we found that the mild hypothermia
(lanes 7–9) could attenuate the isoflurane-induced increase in
the γH2A.X level (lanes 4–6) (Figure 2C). The quantification
of Western blot showed there was a significant difference on
the levels of γH2A.X among the control condition (100%, white
bar), isoflurane treatment (318%, black bar), and hypothermia
plus isoflurane (108%, shadow bar; F = 18.10, ∗∗P = 0.0029;
Figure 2D). γH2A.X is a maker of DNA damage (Bonner et al.,
2008; Garcia-Canton et al., 2012; Valdiglesias et al., 2013; Ni
et al., 2016), thus, these data suggest that hypothermia was able
to attenuate the isoflurane-induced DNA damage.
Hypothermia Attenuated the
Isoflurane-Induced Decrease in ATP Levels
Isoflurane has been shown to induce the cytotoxicity by
decreasing ATP levels (Zhang et al., 2010, 2012). We therefore
determined whether the mild hypothermia could affect the
isoflurane-induced changes in ATP levels. In this experiment,
we treated the cells with 3% isoflurane for 3 h, but not 6 h to
test whether the short time (3 h) isoflurane treatment was able
to decrease the ATP levels without causing cytotoxicity in the
cells. We found that the treatment with 2% isoflurane for 3 h
decreased ATP levels as compared to the control condition, and
the mild hypothermia rescued the isoflurane-induced reduction
in the ATP levels: control (100%), isoflurane (56%), isoflurane
plus mild hypothermia (78%) (Figure 3A, F = 21.61, ∗∗P =
0.0001, one-way ANOVA). Moreover, we found the treatment
with 2% isoflurane for 3 h did not induce cytotoxicity (MTT
assay) (Figure 3B). These data showed that isoflurane-induced
reduction in ATP levels might occur before the isoflurane-
induced cytotoxicity. These results suggest that isoflurane causes
DNA damage and induces cytotoxicity by decreasing ATP levels,
which can be rescued by the mild hypothermia.
DISCUSSION
Our previous studies showed that the commonly used anesthetic
isoflurane was able to induce neurotoxicity associated with
AD neuropathogenesis [(Xie et al., 2006, 2007; Zhang et al.,
2010, 2012), reviewed in Vutskits and Xie (2016)] and DNA
damage (Ni et al., 2016). Mild hypothermia could protect
cytotoxicity (Andresen et al., 2015). In the present studies,
we determined whether mild hypothermia (35◦C) was able
to attenuate the isoflurane-induced cytotoxicity and DNA
damage. We found that the mild hypothermia attenuated the
isoflurane-induced cytotoxicity (Figure 1) as evidenced by the
FIGURE 2 | Mild hypothermia attenuates the isoflurane-induced DNA damage in H4 cells. (A) Treatment with 2% isoflurane for 6 h (lanes 5–8) increases the
γH2A.X level as compared to the control condition (lanes 1–4) in the H4 cells. There is no significant difference in the β-actin level between the isoflurane treatment and
control condition. (B) Quantification of the Western blot, normalized to β-actin level, shows that the isoflurane treatment (black bar) increases the γH2A.X level as
compared to the control condition (white bar) in the cells. (C) Treatment with 2% isoflurane for 6 h plus hypothermia (lanes 7–9) leads to lesser increase in the γH2A.X
level as compared to the isoflurane treatment alone (lanes 4–6) in the H4 cells. There is no significant difference in the β-actin levels among the isoflurane plus
hypothermia, isoflurane treatment alone and control condition. (D) Quantification of the Western blot, normalized to β-actin level, shows that the isoflurane treatment
(black bar) increases γH2A.X level as compared to control condition (white bar) in the cells. The mild hypothermia treatment (net bar) attenuates the isoflurane-induced
increases γH2A.X level (black bar). Phosphorylation of the histone protein H2A variant X at Ser139 (γH2A.X). N = 6–8 in each group. **Indicates that there are
significant differences between control condition and isoflurane treatment in γH2A.X levels (Panels B,D). ## Indicates that there are significant differences between
isoflurane treatment and isoflurane plus mild hypothermia treatment in γH2A.X levels (Panel D).
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FIGURE 3 | Mild hypothermia attenuates the isoflurane-induced cytotoxicity though mitigating the ATP reduction in H4 cells. (A) Treatment with 2%
isoflurane for 3 h (black bar) decreases the ATP level as compared to the control condition (white bar). Treatment with 2% isoflurane for 3 h plus hypothermia (net bar)
leads to a lesser decreases in ATP level as compared to the isoflurane treatment alone (black bar) in the H4 cells. (B) Treatment with 2% isoflurane for 3 h (black bar)
or 2% isoflurane for 3 h plus mild hypothermia (net bar) does not significantly affect the MTT levels as compared to the control condition (white bar) in the H4 cells.
3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT). N = 6–8 in each group. **Indicates that there are significant differences between control condition
and isoflurane treatment in ATP levels (Panel A). ## Indicates that there are significant differences between isoflurane treatment and isoflurane plus mild hypothermia
treatment in ATP levels (Panel A).
changes in the levels of MTT and LDH (Figure 1). Then,
we were able to show that the mild hypothermia could
attenuate the isoflurane-induced DNA damage as evidenced
by that the isoflurane-induced elevation in the levels of
γH2A.X were reduced by the treatment of hypothermia.
Taken together, these data suggest that the mild hypothermia
would protect the isoflurane-induced cytotoxicity by mitigating
the isoflurane-induced DNA damage. It is unknown whether
the mild hypothermia could also attenuate the isoflurane
neurotoxicity in mice. The future studies should include the
investigation of whether mild hypothermia could rescue the
anesthesia-induced neurotoxicity and neurobehavioral deficits in
rodents.
Hypothermia could protect the brain and other vital organs
during periods of ischemia as well as acute brain injuries
(Andresen et al., 2015). Different temperatures may have
different effects on cellular functions. Specifically, hypothermia
with the temperature of 26–30◦C has been reported to induce
Tau phosphorylation (Planel et al., 2007, 2009). However, mild
or moderate hypothermia could reduce brain damage and
neurological deficits before and during cerebral ischemia (Nagel
et al., 2008). The future studies should include the systematic
investigations to assess the interaction of anesthesia and different
temperatures (e.g., 26–35◦C) on cell viability, DNA damage and
ATP levels.
Mild hypothermia seemed even safer and more effective as
compared to moderate hypothermia (WSC, 1997). Thus, it is
important to extend the current findings to rodents and even
humans in the future to determine whether mild hypothermia
could also be used to treat or prevent the postoperative cognitive
dysfunction and postoperative delirium in surgical patients.
We further found that mild hypothermia could also rescue
the reduction in ATP levels induced by the treatment with 2%
isoflurane for 3 h (Figure 3A). Note that this 3 h isoflurane
treatment did not cause cytotoxicity (e.g., reduction in MTT
levels; Figure 3B). The treatment with 2% isoflurane for 3 h did
FIGURE 4 | Hypothesized pathway that mild hypothermia attenuates
the isoflurane-induced DNA damage and cytotoxicity. Isoflurane reduces
ATP levels, which induces DNA damage, and consequently cytotoxicity. Mild
hypothermia inhibits the isoflurane-induced reduction in ATP levels, which
attenuates the isoflurane-induced DNA damage and cytotoxicity.
not cause DNA damage either (Ni et al., 2016). These data suggest
that the isoflurane-induced ATP reduction could occur before
the isoflurane-induced DNA damage and cytotoxicity in the cells.
Collectively, these findings suggest a hypothesized pathway that
isoflurane may cause ATP depletion first, which then induces
DNA damage and finally cytotoxicity (Figure 4). Moreover, the
mild hypothermia could attenuate the isoflurane-induced DNA
damage and cytotoxicity by preventing the isoflurane-induced
reduction in ATP levels (Figure 4).
The current studies have several limitations. First, we did not
compare the effects of different temperatures on the isoflurane-
induced cytotoxicity, DNA damage and reduction in ATP
levels. However, the major goal of the current studies was to
establish a model to assess whether there is an interaction of
hypothermia and isoflurane on cytotoxicity, DNA damage and
ATP levels. The future studies should include the systematic
investigation of the effects of the different temperatures with
various times on the isoflurane-induced cytotoxicity, DNA
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damage and reduction in ATP levels. Second, we did not assess
the effects of mild hypothermia (35◦C) alone on cell viability,
DNA damage and ATP levels. This is mainly because the previous
studies have shown that the mild hypothermia (35◦C) itself
does not significantly affect cell viability and DNA damage in
cultured cells (L’Ecuyer et al., 2012). Third, hypothermia has
been reported to induce Tau phosphorylation (Planel et al.,
2007, 2009). We did not detect the Tau phosphorylation
in the current studies. However, the temperature reported
to induce Tau phosphorylation was between 26 and 30◦C
(Planel et al., 2007, 2009). Thus, it was unlikely that the
mild hypothermia (35◦C) could induce Tau phosphorylation in
the cells in the current studies. Moreover, the current studies
mainly serve as the proof of a concept that mild hypothermia
was able to mitigate the isoflurane-induced cytotoxicity and
DNA damage via attenuating the isoflurane-induced reduction
in ATP levels. Nevertheless, we will determine the effects
of mild hypothermia on Tau phosphorylation in the future
studies.
In conclusion, we found that mild hypothermia could
attenuate the isoflurane-induced DNA damage, cytotoxicity,
and reduction in ATP levels in H4 human neuroglioma cells.
Moreover, the inhibition of the reduction in ATP levels could
be one of the cellular mechanisms by which mild hypothermia
attenuated the isoflurane-induced DNA damage and cytotoxicity.
These findings suggest that we could use mild hypothermia to
treat or prevent the anesthesia neurotoxicity, pending further
investigation.
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